Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Brachytherapy|April 7, 2021
ACR-ABS-ACNM-ASTRO-SIR-SNMMI practice parameter for selective internal radiation therapy or radioembolization for treatment of liver malignanciesKelvin Hong, Olaguoke Akinwande, Lisa Bodei, et al.
The Lancet. Oncology|July 1, 2024
Imaging with [<sup>89</sup>Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trialSalomon Tendler, Mark P Dunphy, Matthew Agee, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
First-in-human imaging with [<sup>89</sup>Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostateSalomon Tendler, Mark P Dunphy, Matthew Agee, et al.
Theranostics|November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applicationsKeifer Kurtz, Laura Eibler, Megan M Dacek, et al.
The Lancet. Oncology|November 18, 2021
<sup>177</sup>Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trialJonathan R Strosberg, Martyn E Caplin, Pamela L Kunz, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2026
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancersSalomon Tendler, Roberto De Gregorio, Paul Balderes, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|November 18, 2017
The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progressionPier Luigi Filosso, Mark Kidd, Matteo Roffinella, et al.
Neuroendocrinology|July 24, 2025
Loss of DAXX/ATRX Protein Expression Results in Ischemia Resistance and Radiation Sensitivity in Pancreatic Neuroendocrine Tumor Cells and Is Associated with Improved Response to Trans-Arterial RadioembolizationJessica C Puzzuoli, Caleb Solivio, Gavin Yuan, et al.
American Journal of Clinical Oncology|May 4, 2022
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE TherapyCharito Love, Neil B Desai, Tony Abraham, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2019
EANM procedure guidelines for radionuclide therapy with <sup>177</sup>Lu-labelled PSMA-ligands (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang Peter Fendler, Matthias Eiber, et al.
Pageof 19